CTOs on the Move

The MUHC Redevelopment Project

www.muhc.ca

 
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.muhc.ca
  • 2155 rue Guy
    MontríŠal, QC CAN H3H 2R9
  • Phone: 514.934.8317

Executives

Name Title Contact Details

Similar Companies

Aurora Diagnostics

Aurora Diagnostics is a leading independent pathology services and cancer diagnostics company, offering integrated diagnostic and personalized medicine consultations and information technology solutions to physicians and hospital systems. Our pathologists provide diagnostic opinions and work collaboratively with referring physicians to determine appropriate patient treatment options. We also provide services to pharmaceutical companies and other research entities to support their efforts to develop new cancer treatments. Our client-centric approach to providing diagnostic services is driven by our belief that the practice of medicine and the delivery of healthcare are both personal and best delivered locally. With our extensive pathology expertise, Aurora Diagnostics is able to support comprehensive integrated approaches to patient care.

PPD Global Central Labs

PPD Global Central Labs is a Newport, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CEDRA Clinical Research

CEDRA Clinical Research is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mtech Laboratories

Mtech Laboratories is a Ballston Lake, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Good Start Genetics

Good Start Genetics is an innovative molecular diagnostics company harnessing a powerful, proprietary next-generation DNA sequencing (NGS) capability combined with other technologies to deliver best-in-class tests for routine genetic screening. Through its GoodStart Select(TM) offering, the company provides the most comprehensive and clinically actionable set of tests for known and novel mutations that cause inherited diseases. Good Start`s NGS capabilities can be applied to multiple disease areas, including pre-conception carrier screening in the in-vitro fertilization setting.